Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma

TY - JOUR

T1 - Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma

AU - Malafa M, Strom T, Shridhar R, Mellon E, Hoffe S, Springett G, Frakes J, Hodul P,

AU - Chuong, Michael

N1 - PURPOSE: Limited data are available to guide neoadjuvant treatment of borderline resectable (BRPC) and locally advanced (LAPC) pancreatic cancer. MATERIAL AND METHODS: We updated our institutional outcomes with a neoadjuvant chemotherapy and stereotactic body radiotherapy (SBRT) approach. An IRB-approved analysis was performed of all BRPC and LAPC patients treated with our departmental treatment protocol.

PY - 2015

Y1 - 2015

UR - https://www.ncbi.nlm.nih.gov/pubmed/25734581

M3 - Article

VL - 54

JO - Acta oncologica

JF - Acta oncologica

ER -